Incidence, Age-Specific, and Regional Distribution of Myocardial Infarction in Zanjan Province, Iran, during 2014-2019
PDF
HTML

Keywords

Incidence rate
Myocardial infarction
Regional and time distribution
Zanjan

Categories

How to Cite

Soleimani, M., Jalilvand, A. ., Soleimani, R. ., & Kamali, K. (2021). Incidence, Age-Specific, and Regional Distribution of Myocardial Infarction in Zanjan Province, Iran, during 2014-2019. Iranian Red Crescent Medical Journal, 23(8). https://doi.org/10.32592/ircmj.2021.23.8.1033

Abstract

Background: Myocardial Infarction (MI) is one of the most important cardiovascular diseases and the leading cause of 39% of deaths in Iran. Due to the different geographical diversity in Zanjan province, Iran, this study aimed to investigate the incidence, age-specific, and regional distribution of myocardial infarction in Zanjan province, Iran.

Methods: This cross-sectional study was conducted at Zanjan University of Medical Sciences (ZUMS), Zanjan, Iran, in 2020. Data were collected from nine hospital information systems. The incidence rate, age-specific, and regional distribution of MI were calculated for each county. Chi-square test, independent sample t-test, and binary logistic regression methods were used to investigate significant relationships between variables. All statistical analyses were performed using RStudio and R software.

Results: In total, 3,723 MI patients were hospitalized in ZUMS hospitals during 2014-2019. The overall incidence rate of MI was 348 cases (95% CI, 337-359) per 100,000 population. Moreover, the prevalence of this condition was higher in males compared to females and at age 80 and over. The incidence rates of MI increased by 84% from 49 cases (95% CI: 47-55) in 2014 to 90 cases (95% CI: 88-99) in 2019 (P<0001). Moreover, the highest incidence rate of MI was observed in Khorramdareh and Ijrood counties.

Conclusion: This study provided an overview of the current status of MI incidence in Zanjan province, Iran. The highest incidence of MI was observed in males and at the southeast of the studied area. This study can help health authorities and policymakers prioritize resource allocation and employ prevention programs to reduce the incidence rate of MI.

https://doi.org/10.32592/ircmj.2021.23.8.1033
PDF
HTML

References

  1. Ahmadi A, Soori H, Mehrabi Y, Etemad K. Spatial analysis of myocardial infarction in Iran: National report from the Iranian myocardial infarction registry. J Res Med Sci. 2015;20(5):434-9. doi: 10.4103/1735-1995.163955. [PubMed: 26487871].
  2. Mechanic OJ, Grossman SA. Acute myocardial infarction. Treasure Island (FL): StatPearls Publishing; 2020.
  3. Mohseni J, Kazemi T, Maleki MH, Beydokhti H. A systematic review on the prevalence of acute myocardial infarction in Iran. Heart Views. 2017;18(4):125-32. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_71_17. [PubMed: 29326775].
  4. Yang HY, Huang JH, Hsu CY, Chen YJ. Gender differences and the trend in the acute myocardial infarction: a 10-year nationwide population-based analysis. Sci World J. 2012;2012:184075. doi: 10.1100/2012/184075. [PubMed: 22997490].
  5. Jalilvand A, Soleimani R, Soleimani M. Geographical epidemiology of cardiovascular diseases in Zanjan province: analysis of groups from the international classification of diseases, 10th revision. J Adv Med Biomed Res. 2020;28(127):90-6. doi: 10.30699/jambs.28.127.90.
  6. Ahmadi A, Soori H, Mehrabi Y, Etemad K, Samavat T, Khaledifar A. Incidence of acute myocardial infarction in Islamic Republic of Iran: a study using national registry data in 2012. East Mediterr Health J. 2015;21(1):5-12. doi: 10.26719/2015.21.1.5. [PubMed: 25907187].
  7. Rumana N, Kita Y, Turin TC, Murakami Y, Sugihara H, Morita Y, et al. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI registry, 1990–2001. Am J Epidemiol. 2008;167(11):1358-64. doi: 10.1093/aje/kwn064. [PubMed: 18381360].
  8. Havulinna AS, Pääkkönen R, Karvonen M, Salomaa V. Geographic patterns of incidence of ischemic stroke and acute myocardial infarction in Finland during 1991-2003. Ann Epidemiol. 2008;18(3):206-13. doi: 10.1016/j.annepidem.2007.10.008. [PubMed: 18280920].
  9. Smolina K, Wright F, Rayner M, Goldacre M. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ. 2012;344:d8059. doi: 10.1136/bmj.d8059. [PubMed: 22279113].
  10. Kjærulff TM, Bihrmann K, Andersen I, Gislason GH, Larsen ML, Ersbøll AK. Geographical inequalities in acute myocardial infarction beyond neighbourhood-level and individual-level sociodemographic characteristics: a Danish 10-year nationwide population-based cohort study. BMJ Open. 2019;9(2):e024207. doi: 10.1136/bmjopen-2018-024207. [PubMed: 30826794].
  11. Rothwell PN, Coull AJ, Silver LE. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366(9499):1773-83. doi: 10.1016/S0140-6736(05)67702-1. [PubMed: 16298214].
  12. Moryś JM, Bellwon J, Höfer S, Rynkiewicz A, Gruchała M. Quality of life in patients with coronary heart disease after myocardial infarction and with ischemic heart failure. Arch Med Sci. 2016;12(2):326-33. doi: 10.5114/aoms.2014.47881. [PubMed: 27186176].
  13. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010;35(2):72-115. doi: 10.1016/j.cpcardiol.2009.10.002. [PubMed: 20109979].
  14. Ahmadi A, Mobasheri M, Soori H. Prevalence of major coronary heart disease risk factors in Iran. Int J Epidemiol Res. 2014;1(1):3-8.
  15. Kränkel N, Blankenberg S, Zeller T. Early detection of myocardial infarction-microRNAs right at the time? Ann Transl Med. 2016;4(24):502-. doi: 10.21037/atm.2016.12.12. [PubMed: 28149864].
  16. Jalilvand A, Soleimani R, Soleimani M. Discrepancy between admission diagnosis and discharge diagnosis in cardiovascular diseases: an analysis based on the groups of international classification disease, 10th revision. J Health Manag Inform. 2020;7(2):100-6.
  17. Doostkami H, Hosseinian A, Fatehi G. Prevalence of NonST-Elevated myocardial infarction among patients hospitalized with initial diagnosis of unstable angina in Ardabil Buali Hospital, 2002. J Ardabil Univ Med Sci. 2006;6(1):37-43.
  18. Ebrahimi K, Khadem Vatan K, Salarilak S, Gharaaghaji R. Epidemiological features of risk factors occurrence and outcomes of myocardial infraction in patients admitted to hospitals in west azerbaijan province during the years 2011 and 2012. Stud Med Sci. 2015;26(8):724-34.
  19. Fakhrzadeh H, Bandarian F, Adibi H, Samavat T, Malekafzali H, Hodjatzadeh E, et al. Coronary heart disease and associated risk factors in Qazvin: a population-based study. East Mediterr Health J. 2008;14(1):33-41. [PubMed: 18557450].
  20. Namayande MS, Nejadkoorki F, Namayande SM, Dehghan H. Spatial hotspot analysis of acute myocardial infarction events in an urban population: a correlation study of health problems and industrial installation. Iran J Public Health. 2016;45(1):94-101. [PubMed: 27057527].
  21. Takii T, Yasuda S, Ito K, Shiba N, Shirato K, Shimokawa H. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI registry study. Circ J. 2009;74(1):93-100. doi: 10.1253/circj.cj-09-0619. [PubMed: 19942783].
  22. Reynolds K, Go AS, Leong TK, Boudreau DM, Cassidy-Bushrow AE, Fortmann SP, et al. Trends in incidence of hospitalized acute myocardial infarction in the cardiovascular research network (CVRN). Am J Med. 2017;130(3):317-27. doi: 10.1016/j.amjmed.2016.09.014. [PubMed: 27751900].
  23. Talbott EO, Rager JR, Brink LL, Benson SM, Bilonick RA, Wu WC, et al. Trends in acute myocardial infarction hospitalization rates for US States in the CDC tracking network. PLoS One. 2013;8(5):e64457. doi: 10.1371/journal.pone.0064457. [PubMed: 23717617].
  24. Sharif Nia H, Sivarajan-Froelicher E, Haghdoost AA, Moosazadeh M, Huak-Chan Y, Farsavian AA, et al. The estimate of average age at the onset of acute myocardial infarction in Iran: a systematic review and meta-analysis study. ARYA Atheroscler. 2018;14(5):225-32. doi: 10.22122/arya.v14i5.1739. [PubMed: 30783413].
  25. Kim Y, Ahn Y, Cho MC, Kim CJ, Kim YJ, Jeong MH. Current status of acute myocardial infarction in Korea. Korean J Intern Med. 2019;34(1):1-10. doi: 10.3904/kjim.2018.381. [PubMed: 30612415].
  26. Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European society of cardiology: cardiovascular disease statistics 2019. Eur Heart J. 2019;41(1):12-85. doi: 10.1093/eurheartj/ehz859. [PubMed: 31820000].
  27. Barr CD, Diez DM, Wang Y, Dominici F, Samet JM. Comprehensive smoking bans and acute myocardial infarction among Medicare enrollees in 387 US counties: 1999-2008. Am J Epidemiol. 2012;176(7):642-8. doi: 10.1093/aje/kws267. [PubMed: 22986145].
  28. Ahmadi A, Soori H, Sajjadi H, Nasri H, Mehrabi Y, Etemad K. Current status of the clinical epidemiology of myocardial infarction in men and women: a national cross-sectional study in Iran. Int J Prev Med. 2015;6(1):14. doi: 10.4103/2008-7802.151822. [PubMed: 25789146].
  29. Insam C, Paccaud F, Marques-Vidal P. Trends in hospital discharges, management and in-hospital mortality from acute myocardial infarction in Switzerland between 1998 and 2008. BMC Public Health. 2013;13:270. doi: 10.1186/1471-2458-13-270. [PubMed: 23530470].
  30. Al-Lawati J, Sulaiman K, Panduranga P. The epidemiology of acute coronary syndrome in Oman: results from the Oman-RACE study. Sultan Qaboos Univ Med J. 2013;13(1):43-50. doi: 10.12816/0003194. [PubMed: 23573381].
  31. Thalib L, Zubaid M, Rashed W, Almahmeed W, Al-Lawati J, Sulaiman K, et al. Regional variability in hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction: findings from the gulf registry of acute coronary events. Med Princ Pract. 2011;20(3):225-30. doi: 10.1159/000323595. [PubMed: 21454991].
  32. Vázquez-Oliva G, Zamora A, Ramos R, Marti R, Subirana I, Grau M, et al. Acute myocardial infarction population incidence and mortality rates, and 28-day case-fatality in older adults. The REGICOR study. Rev Esp Cardiol. 2018;71(9):718-25. doi: 10.1016/j.rec.2017.10.019. [PubMed: 29174866].
  33. Manderbacka K, Hetemaa T, Keskimäki I, Luukkainen P, Koskinen S, Reunanen A. Are there socioeconomic differences in myocardial infarction event rates and fatality among patients with angina pectoris? J Epidemiol Community Health. 2006;60(5):442-7. doi: 10.1136/jech.2005.041566. [PubMed: 16614336].
  34. Manrique-Garcia E, Sidorchuk A, Hallqvist J, Moradi T. Socioeconomic position and incidence of acute myocardial infarction: a meta-analysis. J Epidemiol Community Health. 2011;65(4):301-9. doi: 10.1136/jech.2009.104075. [PubMed: 20841371].
  35. Donyavi T, Naieni KH, Nedjat S, Vahdaninia M, Najafi M, Montazeri A. Socioeconomic status and mortality after acute myocardial infarction: a study from Iran. Int J Equity Health. 2011;10(1):9. doi: 10.1186/1475-9276-10-9. [PubMed: 21299888].
  36. Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis or silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis. 2011;104(3):178-88. doi: 10.1016/j.acvd.2010.11.013. [PubMed: 21497307].